This weekly stock market recap Buydy view closes Oct 5 to Oct 9, 2026 with 5 heatmap highlights and 53 index signals. The goal is a calmer research queue, not a prediction about next week.
Week in brief
On the heatmap, MRL.MC, ORNAV.HE, ORNBV.HE, TIETO.HE stood out as quality-decliner names worth a second pass. They were not selected because they fell the most, but because the selloff appeared beside stronger peer-relative metrics.
What stood out
On the index side, ISEQ 20, CAC 40 (price), CAC Large 60, CAC Mid 60 crossed monitored levels. That gives the week a macro backdrop before any single company gets reviewed.
How to use Buydy this week
Start with the indexes page for market tone, then use the heatmap to find names where price weakness and peer-relative quality sit together. Keep the shortlist small, open only the company pages that deserve real work, and treat every signal as research context.
Heatmap snapshot
How to read this
- These are large-cap stocks that fell recently but still rank well versus peers in their sector.
- Green cells mean stronger than peers; red means weaker. Gray is neutral or inconclusive.
- Score is a peer-relative quality score — not a buy or sell recommendation.
Quality decliners worth a look
Friday, October 9, 2026
Today's top 5 large-cap decliners — price down in at least one period (1W–1Y), ranked by sector percentiles across metrics ≤1Y.
|
Real Estate
Price trend: 3M: -19.2%
|
Dividend Yield (TTM)
53%
|
3M Dividend Yield
38%
|
|
6M Dividend Yield
52%
|
3M Dividend Growth
92%
|
|
6M Dividend Growth
23%
|
1Y Dividend Growth
67%
|
|
D/E Ratio
36%
|
D/E Change 3M
0%
|
|
D/E Change 6M
0%
|
D/E Change 1Y
34%
|
|
Net Debt/EBITDA
55%
|
Net Debt/EBITDA Change 3M
4%
|
|
Net Debt/EBITDA Change 6M
8%
|
Net Debt/EBITDA Change 1Y
5%
|
|
EBITDA
72%
|
EBITDA Growth 3M
100%
|
|
EBITDA Growth 6M
93%
|
EBITDA Growth 1Y
100%
|
|
Net Debt
74%
|
Net Debt Change 3M
35%
|
|
Net Debt Change 6M
23%
|
Net Debt Change 1Y
27%
|
|
Gross Margin
86%
|
EBIT Margin
100%
|
|
EBIT Margin Change 1Y
100%
|
Opex / Sales
44%
|
|
Gross–EBIT Spread
1%
|
FCF Yield
38%
|
|
FCF Margin
49%
|
FCF Margin Change 1Y
83%
|
|
Capex / Sales
11%
|
FCF / Net Income
85%
|
|
Accrual Gap / Sales
34%
|
ROE
62%
|
|
ROE − Cash ROE
34%
|
Interest Coverage
93%
|
|
Cash ROE
30%
|
Opex / Gross Profit
36%
|
|
CFO / Net Income
83%
|
P/E (TTM)
28%
|
|
P/E (1M)
30%
|
P/E (3M)
12%
|
|
P/E (6M)
21%
|
P/E (1Y)
49%
|
|
DCF Upside %
51%
|
Peter Lynch Upside %
76%
|
|
|
Healthcare
Price trend: 1W: -0.2%
|
Dividend Yield (TTM)
61%
|
3M Dividend Yield
45%
|
|
6M Dividend Yield
62%
|
3M Dividend Growth
100%
|
|
6M Dividend Growth
100%
|
1Y Dividend Growth
99%
|
|
D/E Ratio
30%
|
D/E Change 3M
3%
|
|
D/E Change 6M
0%
|
D/E Change 1Y
0%
|
|
Net Debt/EBITDA
76%
|
Net Debt/EBITDA Change 3M
1%
|
|
Net Debt/EBITDA Change 6M
0%
|
Net Debt/EBITDA Change 1Y
0%
|
|
EBITDA
49%
|
EBITDA Growth 3M
88%
|
|
EBITDA Growth 6M
12%
|
EBITDA Growth 1Y
98%
|
|
Net Debt
76%
|
Net Debt Change 3M
0%
|
|
Net Debt Change 6M
0%
|
Net Debt Change 1Y
0%
|
|
Gross Margin
63%
|
EBIT Margin
96%
|
|
EBIT Margin Change 1Y
80%
|
Opex / Sales
15%
|
|
Gross–EBIT Spread
33%
|
FCF Yield
54%
|
|
FCF Margin
74%
|
FCF Margin Change 1Y
70%
|
|
Capex / Sales
40%
|
FCF / Net Income
32%
|
|
Accrual Gap / Sales
92%
|
ROE
94%
|
|
ROE − Cash ROE
92%
|
Interest Coverage
97%
|
|
Cash ROE
84%
|
Opex / Gross Profit
6%
|
|
CFO / Net Income
21%
|
P/E (TTM)
39%
|
|
P/E (1M)
59%
|
P/E (3M)
88%
|
|
P/E (6M)
69%
|
P/E (1Y)
68%
|
|
DCF Upside %
36%
|
Peter Lynch Upside %
86%
|
|
|
Healthcare
Price trend: 1W: 0.0%
|
Dividend Yield (TTM)
59%
|
3M Dividend Yield
44%
|
|
6M Dividend Yield
62%
|
3M Dividend Growth
100%
|
|
6M Dividend Growth
100%
|
1Y Dividend Growth
99%
|
|
D/E Ratio
30%
|
D/E Change 3M
3%
|
|
D/E Change 6M
0%
|
D/E Change 1Y
0%
|
|
Net Debt/EBITDA
76%
|
Net Debt/EBITDA Change 3M
1%
|
|
Net Debt/EBITDA Change 6M
0%
|
Net Debt/EBITDA Change 1Y
0%
|
|
EBITDA
49%
|
EBITDA Growth 3M
88%
|
|
EBITDA Growth 6M
12%
|
EBITDA Growth 1Y
98%
|
|
Net Debt
76%
|
Net Debt Change 3M
0%
|
|
Net Debt Change 6M
0%
|
Net Debt Change 1Y
0%
|
|
Gross Margin
63%
|
EBIT Margin
96%
|
|
EBIT Margin Change 1Y
80%
|
Opex / Sales
15%
|
|
Gross–EBIT Spread
33%
|
FCF Yield
54%
|
|
FCF Margin
74%
|
FCF Margin Change 1Y
70%
|
|
Capex / Sales
40%
|
FCF / Net Income
32%
|
|
Accrual Gap / Sales
92%
|
ROE
94%
|
|
ROE − Cash ROE
92%
|
Interest Coverage
97%
|
|
Cash ROE
84%
|
Opex / Gross Profit
6%
|
|
CFO / Net Income
21%
|
P/E (TTM)
39%
|
|
P/E (1M)
59%
|
P/E (3M)
88%
|
|
P/E (6M)
69%
|
P/E (1Y)
67%
|
|
DCF Upside %
36%
|
Peter Lynch Upside %
86%
|
|
|
Technology
Price trend: 1M: -1.7%
|
Dividend Yield (TTM)
96%
|
3M Dividend Yield
71%
|
|
6M Dividend Yield
68%
|
3M Dividend Growth
49%
|
|
6M Dividend Growth
35%
|
1Y Dividend Growth
84%
|
|
D/E Ratio
76%
|
D/E Change 3M
53%
|
|
D/E Change 6M
45%
|
D/E Change 1Y
26%
|
|
Net Debt/EBITDA
89%
|
Net Debt/EBITDA Change 3M
9%
|
|
Net Debt/EBITDA Change 6M
5%
|
Net Debt/EBITDA Change 1Y
3%
|
|
EBITDA
56%
|
EBITDA Growth 3M
97%
|
|
EBITDA Growth 6M
97%
|
EBITDA Growth 1Y
100%
|
|
Net Debt
90%
|
Net Debt Change 3M
38%
|
|
Net Debt Change 6M
15%
|
Net Debt Change 1Y
13%
|
|
Gross Margin
27%
|
EBIT Margin
75%
|
|
EBIT Margin Change 1Y
100%
|
Opex / Sales
1%
|
|
Gross–EBIT Spread
1%
|
FCF Yield
86%
|
|
FCF Margin
48%
|
FCF Margin Change 1Y
43%
|
|
Capex / Sales
45%
|
FCF / Net Income
79%
|
|
Accrual Gap / Sales
45%
|
ROE
39%
|
|
ROE − Cash ROE
35%
|
Interest Coverage
61%
|
|
Cash ROE
55%
|
Opex / Gross Profit
1%
|
|
CFO / Net Income
77%
|
P/E (TTM)
9%
|
|
P/E (1M)
49%
|
P/E (3M)
63%
|
|
P/E (6M)
41%
|
P/E (1Y)
62%
|
|
DCF Upside %
83%
|
Peter Lynch Upside %
86%
|
|
|
Energy
Price trend: 1M: -6.9%
|
Dividend Yield (TTM)
63%
|
3M Dividend Yield
58%
|
|
6M Dividend Yield
62%
|
3M Dividend Growth
80%
|
|
6M Dividend Growth
76%
|
1Y Dividend Growth
27%
|
|
D/E Ratio
0%
|
D/E Change 3M
68%
|
|
D/E Change 6M
0%
|
D/E Change 1Y
0%
|
|
Net Debt/EBITDA
51%
|
Net Debt/EBITDA Change 3M
82%
|
|
Net Debt/EBITDA Change 6M
0%
|
Net Debt/EBITDA Change 1Y
0%
|
|
EBITDA
37%
|
EBITDA Growth 3M
74%
|
|
EBITDA Growth 6M
77%
|
EBITDA Growth 1Y
64%
|
|
Net Debt
47%
|
Net Debt Change 3M
94%
|
|
Net Debt Change 6M
0%
|
Net Debt Change 1Y
0%
|
|
Gross Margin
70%
|
EBIT Margin
67%
|
|
EBIT Margin Change 1Y
100%
|
Opex / Sales
33%
|
|
Gross–EBIT Spread
62%
|
FCF Yield
73%
|
|
FCF Margin
94%
|
FCF Margin Change 1Y
81%
|
|
Capex / Sales
63%
|
FCF / Net Income
91%
|
|
Accrual Gap / Sales
8%
|
ROE
91%
|
|
ROE − Cash ROE
5%
|
Interest Coverage
47%
|
|
Cash ROE
96%
|
Opex / Gross Profit
33%
|
|
CFO / Net Income
87%
|
P/E (TTM)
75%
|
|
P/E (1M)
12%
|
P/E (3M)
43%
|
|
P/E (6M)
25%
|
P/E (1Y)
76%
|
|
DCF Upside %
25%
|
Peter Lynch Upside %
19%
|
|
Only large-cap stocks with complete sector data for every metric shown. Score = weighted average of sector percentiles. Symbol links open Buydy; Yahoo links are secondary.
Win (≥70%)
Loss (<60%)
No decision (60–70%)
Open Heatmap · Open Indexes
Next steps
Use this recap as a starting point: open Buydy pricing, follow the ETF heat map guide, and compare Buydy vs manual research if you still rely on spreadsheets.
